Key result
CPET guides pulmonary hypertension management by aiding differential diagnosis, evaluating exercise intolerance, and generating prognosis.
Answers are grounded in this paper and cite their sources.
Cardiopulmonary exercise testing is a valuable tool for the differential diagnosis, evaluation of exercise intolerance, and prognostication in patients with pulmonary hypertension.
Cardiopulmonary exercise testing (CPET) is of great interest and utility for clinicians dealing Pulmonary Hypertension (PH) in several ways, including: helping with differential diagnosis, evaluating exercise intolerance and its underpinning mechanisms, accurately assessing exertional dyspnea and unmasking its underlying often non-straightforward mechanisms, generating prognostic indicators. Pathophysiologic anomalies in PH can range from reduced cardiac output and aerobic capacity, to inefficient ventilation, dyspnea, dynamic hyperinflation, and locomotor muscle dysfunction. CPET can magnify the PH-related pathophysiologic anomalies and has a major role in the management of PH patients.
No takes yet. Share an insight, caveat, or question.
Laveneziana et al. (2020) conducted a review in Pulmonary Hypertension. Cardiopulmonary exercise testing (CPET) was evaluated. Cardiopulmonary exercise testing plays a major role in managing pulmonary hypertension by aiding differential diagnosis, evaluating exercise intolerance, and generating prognostic indicators.
Synapse has enriched 10 related papers. Consider them for comparative context: